The effect of escitalopram on platelet activity

Thrombosis Research

Volumn 127, Issue 1, 2011, Pages 57-

  Canan, Fatih ^a   Ataoglu, Ahmet ^a  

^a DUZCE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CITALOPRAM; COLLAGEN; ESCITALOPRAM; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE;

CARDIOVASCULAR RISK; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOCYTE;

ANTIDEPRESSIVE AGENTS; BLOOD PLATELETS; CITALOPRAM; DEPRESSION; HUMANS; PLATELET AGGREGATION; TREATMENT OUTCOME;

EID: 78650513996     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.07.017     Document Type: Letter

References (13)

1. A. Flöck, A. Zobel, G. Bauriedel, I. Tuleta, C. Hammerstingl, S. Höfels, et al. Antiplatelet effects of antidepressant treatment: A randomized comparison between escitalopram and nortriptyline. Thromb Res. 2010;126(2):e83-e87.
2. C.B. Nemeroff, and D.L. Musselman Are platelets the link between depression and ischemic heart disease? Am Heart J 140 suppl 4 2000 57 62
3. V.L. Serebruany, P.A. Gurbel, and C.M. O'Connor Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors Pharmacol Res 43 2001 453 462
4. J.C. Alvarez, N. Gluck, I. Arnulf, P. Quintin, M. Leboyer, and R. Pecquery Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine Clin Pharmacol Ther 66 1999 617 624
5. D.L. Musselman, U.M. Marzec, A. Manatunga, S. Penna, A. Reemsnyder, and B.T. Knight Platelet reactivity in depressed patients treated with paroxetine: preliminary findings Arch Gen Psychiatry 57 2000 875 882
6. E. Maurer-Spurej Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection Cell Mol Life Sci 62 2 2005 159 170
7. E. Maurer-Spurej, C. Pittendreigh, and K. Solomons The influence of selective serotonin reuptake inhibitors on human platelet serotonin Thromb Haemost 91 2004 119 128
8. J. Veenstra-VanderWeele, G.M. Anderson, and E.H. Cook Pharmacogenetics and the serotonin system: initial studies and future directions Eur J Pharmacol 410 2000 165 181
9. R. Szasz, and G.L. Dale COAT platelets Curr Opin Hematol 10 2003 351 355
10. M.C. Morel-Kopp, L. McLean, Q. Chen, G.H. Tofler, C. Tennant, and V. Maddison The association of depression with platelet activation: evidence for a treatment effect J Thromb Haemost 7 4 2009 573 581
11. D. Atar, A. Malinin, A. Takserman, A. Pokov, L. van Zyl, and J.F. Tanguay Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans J Clin Psychopharmacol 26 2006 172 177
12. D. Atar, A. Malinin, A. Pokov, L. van Zyl, N. Frasure-Smith, and F. Lesperance Antiplatelet properties of escitalopram in patients with the metabolic syndrome: adose-ranging in vitro study Neurospsychopharmacology 32 2007 2369 2374
13. A. Ataoglu, and F. Canan Mean platelet volume in patients with major depression: effect of escitalopram treatment J Clin Psychopharmacol 29 4 2009 368 371